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23 International coordination and 
cooperation: the next agenda in 
nanomaterials regulation
Robert Falkner, Linda K. Breggin, Nico Jaspers, 
John Pendergrass and Read Porter
Nanotechnologies are set to transform industrial society. They promise 
benefi ts in a wide range of applications, from health care to food, cosmet-
ics, chemicals, information technology and energy storage. The manipu-
lation of matter or creation of structures down to the molecular level 
(typically at a scale of approximately 100 nanometres or less, a nanometre 
being one- billionth of a metre) has led to the creation of novel materi-
als, so- called engineered nanomaterials, which are already being used in 
numerous consumer products. Additional commercial applications can be 
expected in coming years.
Our understanding of how nanomaterials interact with the environ-
ment and the human body has not kept pace with the development of 
nanotechnologies. Early results of research suggest that the safety of all 
nanomaterials cannot be taken for granted (see, for example, the recent 
reviews by the Royal Society and the Royal Academy of Engineering 
(RS- RAE) (2004) and the Royal Commission on Environmental Pollution 
(RCEP) (2008). The ongoing expansion of nanotechnologies may produce 
novel nanostructures that cause currently unknown forms of hazard. 
Developing nanomaterials governance that is both eff ective and propor-
tional to potential risks is critical to the future success of existing and 
emerging nanotechnologies.
The aim of this chapter is to identify key challenges in developing more 
eff ective and internationally coordinated nanomaterials regulation. It 
seeks to stimulate the debate on how to promote more convergent regu-
lation, primarily between the European Union (EU) and United States 
(US), but also at the international level.
The EU and the US are worldwide leaders in the scientifi c and com-
mercial development of nanotechnologies. Their regulatory responses to 
potential risks will send an important signal worldwide. In the past, they 
have cooperated in international eff orts to harmonize their respective 
risk regulation, through the Organisation for Economic Co- operation 
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and Development (OECD) and the World Trade Organization (WTO). 
Where successful, such eff orts have promoted high levels of protection 
from risk while enabling scientists and industries to operate freely in the 
 transatlantic economic space.
In some cases, however, transatlantic coordination and cooperation 
have proved diffi  cult. Diff erences in legislative frameworks, regulatory 
cultures, societal risk perceptions and political dynamics can contribute to 
a divergence of regulatory responses. This was the case, for example, with 
high- profi le transatlantic disputes over hormone- treated beef and geneti-
cally modifi ed food, which have had a negative impact on transatlantic 
relations and trade (Falkner, 2007). These experiences have shown the 
importance of identifying technological risks and promoting international 
cooperation at an early stage in the policy process.
This chapter summarizes key fi ndings and policy recommendations of a 
project that was carried out in 2008–09 by a consortium of research insti-
tutions from both sides of the Atlantic: the London School of Economics 
and Political Science (LSE) and Chatham House (the Royal Institute of 
International Aff airs) in the UK, and the Environmental Law Institute 
(ELI) and the Project on Emerging Nanotechnologies (PEN) at the 
Woodrow Wilson International Center for Scholars in the United States. 
The project, which was funded by a research grant from the European 
Commission and involved extensive consultation with experts and stake-
holders in nanomaterials regulation, resulted in a comparative analysis of 
European and American regulatory frameworks in three areas: chemicals, 
food and cosmetics.
This chapter builds on the main project report, entitled Securing 
the Promise of Nanotechnologies: Towards Transatlantic Regulatory 
Cooperation (Breggin et al., 2009). Its key policy- relevant fi ndings can be 
summarized in the following points:
● Developing nanomaterials governance that is both eff ective and 
proportional to potential environmental, health and safety (EHS) 
risks is critical to the future success of existing and emerging 
nanotechnologies.
● Persistent scientifi c uncertainty could limit the eff ectiveness of exist-
ing regulatory frameworks and risk assessment approaches. Ongoing 
international eff orts to create scientifi c building blocks for risk 
assessment of nanomaterials need to be stepped up and expanded.
● Governments on both sides of the Atlantic need to provide signifi -
cantly increased funding for research into EHS risks of nanomate-
rials; they should also promote greater coordination of research 
funding at an international level.
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● In the light of existing knowledge gaps about the commercial use of 
nanomaterials, the EU and US should aim to enhance market trans-
parency by strengthening existing mandatory reporting  requirements 
and, where necessary, creating new ones.
● Given the contested nature of consumer labelling, US and EU 
authorities should explore the implications of potentially diverging 
labelling requirements for nanomaterials, particularly in the context 
of international trade obligations.
● In view of the ongoing and accelerating globalization of nanotech-
nologies, the EU and the US should complement existing interna-
tional initiatives (for example by the OECD) with the development 
of international governance capacity in other areas (for example 
the United Nations Environment Programme and World Health 
Organization), not least to ensure that developing countries are 
more involved in international decision- making.
This chapter thus argues that securing the promise of nanotechnologies 
will require signifi cant levels of international coordination and coopera-
tion. As global leaders in the development and regulation of nanotech-
nologies, the EU and the US have an important international role to play. 
Transatlantic cooperation in this area has the potential to provide a model 
for enhanced international cooperation and is likely to shape the emer-
gence of future international standards and approaches for dealing with 
potential nanomaterials risks.
23.1  THE GROWING MARKET FOR 
NANOMATERIALS
It is diffi  cult to predict precisely how nanotechnologies and their com-
mercial applications will develop owing to the diversity of potential 
commercial pathways and the complexity of the nanotechnology value 
chain. However, as is discussed by Hodge, Bowman and Maynard in their 
Introduction, the commercial promise of nanotechnologies is beyond 
doubt. This is refl ected not least in growing nanotechnology patent fi lings 
and expanding investment in research by both private companies and 
national governments (Chen et al., 2008; Mandel, 2010).1
Consumers are also beginning to see the fi rst fruits of nanotechnology 
innovation. An inventory2 of consumer products containing nanomaterials 
or enabled by nanotechnologies, maintained by the Project on Emerging 
Nanotechnologies (PEN) at the Woodrow Wilson International Center of 
Scholars, lists over 1000 such products that are currently on the market 
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in 24 diff erent countries. The vast majority of these products appear in 
the cosmetics, clothing, personal care, sporting goods, sunscreens and 
fi ltration sectors and are available primarily on the US market, with East 
Asia and Europe following in second and third place. The materials most 
frequently mentioned as being contained in products are nanoscale silver, 
carbon, titanium, silicon, zinc and gold. While the PEN inventory relies 
on self- identifi ed products and may thus potentially overstate (but also 
understate) the true degree of commercialization of ‘nanoproducts’, it is 
indicative of the wide range of commercial applications of nanotechnolo-
gies in consumer products.
Nanosciences and nanotechnologies are driving the development of a 
broad array of products and industries in various sectors ranging from 
manufacturing and materials to electronics and IT, and healthcare and 
life sciences. For instance, between 2004 and 2006 the value of manu-
factured goods and materials incorporating nanomaterials expanded 
from $US13 billion to $US50 billion, and in 2006, $US1.5 billion worth 
of nano- enabled drugs were sold. Current projections for the future 
growth of commercial applications of nanotechnology range from $US1 
trillion to over $US3 trillion by 2015. But because nanotechnologies are 
enabling technologies, such estimates do not always distinguish clearly 
enough between the more limited value- added of nanotechnologies and 
the larger face- value of products that ‘contain’ nanotechnology prod-
ucts. Nonetheless, market research estimates suggest that by 2014 as 
much as 4 per cent of total manufacturing and materials sector output 
may incorporate nanotechnologies, and 50 per cent of manufactured 
output in electronics and IT and 16 per cent of manufactured goods 
in healthcare and life sciences may be nano- enabled (Lux Research, 
2008).
23.2  REGULATORY CHALLENGES OF 
NANOMATERIALS
Governments in leading industrialized countries are currently relying on 
existing frameworks for EHS regulation to deal with nanotechnology 
risks, making minor adjustments to specifi c regulations and their imple-
mentation in order to close any potential gaps or eliminate uncertain-
ties. These challenges and governments’ responses to them are discussed 
in more detail by, for example, Widmer and Meili (2010) in relation to 
industrial chemicals, van Calster and Bowman (2010) in relation to the use 
of nanomaterials in cosmetic products and Gaspar (2010) in relation to 
therapeutic products.3
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Regulators face a number of challenges in dealing with the potential 
risks of nanomaterials. These challenges are related to a series of uncer-
tainties, with regard to the development and commercial application of 
nanomaterials, hazards and exposure pathways, the direction and speed 
of technological change, and the suitability and eff ectiveness of existing 
regulatory frameworks. Understanding these uncertainties and reacting 
eff ectively and proportionally is imperative for regulators and policy-
 makers as much as for industry and civil society.
Rapid Technological Change
While the current regulatory focus is on passive nanomaterials, future 
developments will include active nanomaterials and are likely to converge 
with other technologies such as information, bio- and cognitive technolo-
gies. These future- generation nanomaterials will develop in ways that are 
diffi  cult to foresee. Regulators will need to constantly expand their knowl-
edge base covering multiple areas of scientifi c and engineering inquiry 
and develop fl exible responses to a constantly changing technological 
environment.
How much funding and time will be required to test the nanomaterials 
fl owing into the marketplace? Neither the OECD nor national regulatory 
bodies have provided public estimates but a recent study indicated that 
assessing the risks of 190 nanomaterials now in production would require 
an investment of $US249 million (assuming optimistic assumptions about 
hazards) (Choi et al., 2009). The use of tiered testing strategies could 
reduce this sum and the current low production volumes of some materi-
als may reduce the need to test at all. But the risk assessment challenge 
is likely to increase in complexity and cost as more materials enter the 
market and, importantly, as second- and third- generation nanotechnology 
products and materials enter commercial production.
Uncertainty of Commercialization Paths
While the number of existing commercial products using nanomaterials 
keeps growing, uncertainty exists regarding future commercialization 
paths. As the range of commercial applications expands, governments 
will have to address potential risks of nanomaterials in diverse regula-
tory contexts covering diff erent industries and commercial applications, 
potentially adding to existing uncertainty about the regulatory coverage 
of nanomaterials risks.
M2421 - HODGE TEXT.indd   512 2/11/10   14:01:30
International coordination and cooperation   513
Uncertainty Regarding Nanomaterials Risks
A lack of data on hazards and exposure pathways of certain nanomateri-
als, combined with uncertainty about the applicability of some existing 
testing methods, are widely recognized impediments to the eff ective imple-
mentation of regulations (see, for example, Chaudhry et al., 2010). Risk 
regulation under conditions of uncertainty is, of course, not uncommon in 
areas such as chemical and food safety. Given the signifi cant knowledge 
gaps on EHS risks of certain nanomaterials, however, it is too early to 
establish whether existing regulatory frameworks can and will be eff ective 
in the face of potential risks. Governments in various countries are cur-
rently engaged in more systematic eff orts to promote research into EHS 
risks and the further development of testing methods, but given rapidly 
evolving nanotechnology research and commercialization, such eff orts 
pose a continuous challenge.
Uncertainty Regarding the Suitability of Regulatory Frameworks
Analysts have debated for some years whether current laws provide ade-
quate oversight for certain applications of nanotechnologies or whether 
new legislative instruments are needed.4 US and EU regulatory agencies 
suggest that the existing regulatory framework, consisting of a range of 
laws and regulations, is broadly suffi  cient to deal with potential risks 
associated with nanomaterials, and that only small adjustments or amend-
ments may be needed to regulations and implementation guidelines, in 
order to close any potential gaps. This, however, remains a matter of 
debate (see, for example, Breggin et al., 2009: 28–83). It is important to 
note that much of this depends on how they are implemented. Adequate 
guidance for implementation and the provision of the necessary resources 
for regulatory oversight thus become critical factors in developing eff ec-
tive regulatory responses. Uncertainty regarding the regulatory capacity 
of existing institutions in this area cannot be ruled out, not least because 
of the novel nature of nanomaterials risks and the limited experiences that 
regulatory agencies have been able to develop in this area.
Uncertainty Regarding Regulatory and Scientifi c Resources
One area that is a recurring theme in debates on regulatory capacity is 
the question of resources for the implementation of risk regulation frame-
works. The challenges that novel technologies such as nanotechnology 
present require signifi cant investment in human resources. Statutes are 
a necessary but insuffi  cient condition for success if the regulators lack 
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enforcement capacity, scientifi c expertise and foresight. It is too early to 
say whether regulatory institutions on both sides of the Atlantic have suf-
fi cient scientifi c capacity to deal with the manifold challenges of regulat-
ing nanomaterials. What is clear, however, is that the public sector will 
increasingly have to compete with industry for talent in these emerging 
technology areas. The search for talent, particularly in the scientifi c area, 
thus needs to become a strategic priority, just as it is already in industry.
23.3  TOWARDS REGULATORY EFFECTIVENESS 
AND CONVERGENCE: POLICY 
RECOMMENDATIONS FOR TRANSATLANTIC 
AND INTERNATIONAL COOPERATION
What should be done to promote more eff ective and internationally con-
vergent regulation of nanomaterials? Based on the comparative analysis 
in our main project report and consultations with relevant experts and 
stakeholders, we identify four clusters of issues that need to be addressed 
as part of future eff orts to strengthen nanomaterials oversight:
● the creation of the scientifi c building blocks that are necessary for 
risk assessment
● the closure of existing knowledge gaps with regard to the commer-
cialization of nanomaterials and potential EHS risks
● questions of societal and ethical perspectives and how they are 
addressed in risk management, especially through labelling, and
● the strengthening of global governance capacity for nanomaterials 
oversight.
Before we develop our policy recommendations in greater detail, we need 
to briefl y explain the use of the notion of regulatory convergence in the 
context of this chapter. We understand convergence to be a process rather 
than a specifi c outcome. It involves the gradual adjustment of regulatory 
frameworks, institutions and practices, but can occur through a variety of 
processes and mechanisms. These range from informal policy diff usion to 
international coordination and cooperation, whether formal or informal, 
and to treaty- based international harmonization eff orts. When speaking 
of the promotion of greater regulatory convergence in the fi eld of nano-
technologies, we therefore have in mind the full range of convergence 
processes that can be observed in other international policy areas, from 
environmental to fi nancial regulation, and from trade policy to investment 
rules.
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While we have focused on ways to promote regulatory convergence, we 
recognize its limits, in terms of both feasibility and desirability. In the area 
of EHS regulation, full harmonization of national rules and practices is 
rarely, if ever, achieved. As discussed in our main report, there are some 
distinctive benefi ts, but also costs, that result from regulatory conver-
gence, and policy- makers ultimately need to decide how to balance these. 
The subsequent discussion refl ects this reality and seeks to enlighten the 
political and regulatory debate by identifying opportunities for, but also 
barriers to, a movement towards greater consistency and convergence at 
the transatlantic and international level.
Creation of Scientifi c Building Blocks
Recent analyses and scientifi c reviews have revealed a number of areas in 
which scientifi c uncertainty is limiting the eff ectiveness of existing regula-
tory frameworks and risk assessment approaches. Fundamental uncertain-
ties exist, for example, with regard to the classifi cation of nanomaterials, 
the precise defi nition of nanotechnology and nanomaterials, identifi cation 
of hazards, exposure levels, and environmental and health eff ects, in par-
ticular over the life- cycle of diff erent nanomaterials (International Council 
on Nanotechnology, 2008; Scientifi c Committee on Consumer Products, 
2007). In their reviews of regulatory frameworks for nanomaterials, both 
EU and US agencies have acknowledged that, while nanomaterials are 
broadly covered by existing frameworks, scientifi c uncertainties remain 
to be resolved in order to strengthen the implementation of regulatory 
oversight mechanisms (European Commission, 2008; EPA, 2007; FDA, 
2007).
Broad agreement exists, therefore, on the need to establish a fi rm sci-
entifi c basis for risk assessment. In order for regulation to work, regula-
tors need data and scientifi c tools to develop a clear understanding of the 
nature of the materials that may cause harm, how to identify these materi-
als, defi ne the diff erent types of risks involved, and establish appropriate 
testing methods and appropriate and eff ective methods of measuring 
nanomaterials in the environment, among others. In a rapidly changing 
fi eld such as that of the nanosciences, where even the boundaries of what 
is considered to be a nanoscale material or structure are as yet ill- defi ned, 
it is of vital importance to establish those basic scientifi c tools as the basis 
for risk assessment and subsequent risk management.
To date, however, many of the scientifi c building blocks, with regard to 
defi nition and characterization of nanomaterials, metrology and testing 
methods, are as yet missing or have not been internationally standardized. 
Regulators and experts in the US, Europe and elsewhere are currently 
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seeking to fi ll existing gaps in this area by working together in various inter-
national forums, such as the OECD and the International Organization 
for Standardization (ISO). Our research suggests that ongoing work on 
creating scientifi c building blocks for risk assessment needs to be stepped 
up and expanded if it is to produce results in a timely fashion. The rapid 
pace of commercialization of nanomaterials demands a greater sense of 
urgency in this area.
Ongoing bilateral links between relevant regulatory authorities, mainly 
from the EU and the US, play an important role in this respect. They 
provide regular opportunities for information exchange and informal 
learning, and they create a space for regulators to learn from one another’s 
experiences away from the political spotlight. Informal links of this kind 
are thus an integral element of an international regulatory convergence 
agenda, but cannot replace more formal, transparent and inclusive proc-
esses that are open to a broader range of countries and stakeholders.
Furthermore, a number of standard- setting bodies have focused on the 
question of scientifi c and technical terminology in the fi eld of nanotech-
nologies. They include international bodies such as the ISO and ASTM 
International, among others. They enjoy a high degree of legitimacy 
among regulators and industry groups, and are set to make a valuable 
contribution to the development of congruent and convergent regulatory 
approaches. Their work is limited in its scope, however, being focused 
exclusively on standardization in technical and scientifi c fi elds, and some 
civil society groups have voiced concerns about a lack of transparency and 
participation in the ISO standardization process.
The OECD, in contrast, plays a much wider role in promoting congru-
ent approaches and, to some extent, international convergence in the 
fi eld of nanomaterials regulation. Having set up two nanotechnology 
working groups in 2006 (Working Party on Manufactured Nanomaterials 
– WPMN) and 2007 (Working Party on Nanotechnology – WPN), it is 
currently the predominant international forum for coordination eff orts by 
regulators and industry experts from the US, the EU and a select group of 
other countries. It enjoys broad legitimacy in promoting coordination on 
the building blocks for risk assessment, and is a central institution in the 
context of transatlantic regulatory convergence. At the same time, more 
political energy and resources need to be invested in the OECD process, 
and greater transparency and inclusiveness should be achieved in its work. 
While it is desirable for the nanotechnology working parties’ inclusiveness 
and transparency to be enhanced in order to facilitate broader participa-
tion and openness, the existing structure of the OECD mitigates against 
a move towards greater transparency and participation. As an organiza-
tion that represents a select group of industrialized countries, is based on 
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inter- governmental decision- making processes and has a limited remit in 
the development of policy guidance and international coordination, the 
OECD is unlikely to become the facilitator of a global dialogue on nano-
technology regulation or the host of a global governance framework for 
nanotechnology.
Closing Knowledge Gaps
Regulators face two important knowledge gaps, on potential EHS risks 
associated with the production and use of nanomaterials and on the 
 presence of nanomaterials in commercial products.
A number of authoritative scientifi c reviews carried out in recent years 
have revealed signifi cant gaps in our understanding of how nanomateri-
als interact with the environment and aff ect the human body. As the 
RS- RAE reported in their 2004 study, many important questions remain 
unanswered with regard to the specifi c properties of nanomaterials, their 
toxicity and environmental behaviour, and levels of exposure throughout 
the life- cycle of nanomaterials. A more recent review by the UK’s RCEP 
emphasized the continued knowledge gaps in this area. Its 2008 assess-
ment concluded that ‘there is a plausible basis for concern that some 
manufactured nanomaterials could present a hazard to human health and 
environment’, and that ‘[h]owever good the research eff ort, signifi cant 
uncertainties and areas of ignorance will remain’ (RCEP, 2008: 55). Thus, 
although there is no evidence of actual harm from current applications of 
nanomaterials, uncertainty about the behaviour of nanomaterials in the 
environment or in living organisms makes it diffi  cult to know whether 
there are adverse eff ects and, if there are, the nature of such eff ects.
A further complication arises from the rapid and often unpredict-
able development and commercialization of nanotechnologies in a global 
context. Technological innovation is proceeding at a pace that govern-
ments are fi nding diffi  cult to keep up with, and, while much of the current 
regulatory focus is on manufactured nanomaterials, few, if any, eff orts are 
being directed at dealing with the regulation of emerging risks resulting 
from future- generation nanotechnologies (see, for example, Davies, 2009, 
2010; Rodemeyer, 2009). But even gaining a sound knowledge base about 
the commercial use of fi rst- generation nanotechnologies poses a challenge 
to regulators today. Uncertainty exists on the extent to which nanomateri-
als are being manufactured and used by companies as well as traded inter-
nationally, making it diffi  cult for regulators to establish unequivocally that 
all current applications of the new technology are adequately covered by 
regulations.
These two dimensions of uncertainty are closely linked and complicate 
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the search for eff ective regulatory approaches. Knowing as soon as possi-
ble what types of nano- enabled products are on the market, what types of 
nanomaterials are used and how they move through possible product life-
 cycles provides some grounding for establishing research needs in the fi eld 
of EHS risks. Uncertainty in both these areas affl  icts regulatory systems 
around the world. International cooperation on reducing uncertainty with 
respect to the commercial use of nanomaterials and on EHS risks would 
help governments in addressing certain regulatory challenges.
EHS risk research
Accordingly, as a matter of priority, governments need to provide sig-
nifi cantly increased funding for research into EHS risks of nanomaterials. 
They should also promote greater coordination of research funding at a 
transatlantic and global level. International research coordination has its 
limits and can be diffi  cult to achieve, but the benefi ts of improved interna-
tional coordination of EHS research outweigh the costs. Against the back-
ground of strained public fi nances and urgent research needs, enhanced 
global cooperation would give a greater sense of strategic direction to 
existing research eff orts and strengthen the basis for sustained research 
funding streams into the future.
Regulators would also benefi t from better access to information avail-
able to their counterparts abroad, particularly in the area of potential 
EHS risks. The sharing of commercially sensitive data poses a problem, 
however, given regulatory approaches to the protection of confi dential 
business information. We encourage regulators and policy- makers to 
explore all options available to them, whether through domestic reform 
or international agreement, to promote better sharing of information on 
EHS risk- related data for nanomaterials while ensuring commercially 
 sensitive data remain protected.
Reporting of nanomaterials in commercial use
A second knowledge gap concerns the state of the commercialization of 
nanomaterials. As mentioned above, uncertainty exists not only about 
EHS risks of nanomaterials but also with regard to the commercial use 
of nanomaterials and, specifi cally, the type of nanomaterials contained 
in intermediate or consumer products. Many companies themselves are 
uncertain about the use of such materials within their own industry, and 
regulators on both sides of the Atlantic have acknowledged that they 
currently do not have comprehensive knowledge about their presence in 
commercially traded goods. Recently introduced voluntary substances 
reporting programmes (for example in the US and UK) are unlikely to 
close such knowledge gaps.
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Existing attempts to establish comprehensive market registers, such as 
PEN’s product inventory, are laudable but need to be taken further. Given 
the persistence of these knowledge gaps, governments on both sides of the 
Atlantic should strengthen existing mandatory reporting requirements 
and, where necessary, create new ones, with a view to gaining a compre-
hensive overview of the commercial use of nanomaterials. Given the high 
degree of interdependence in the global economy, any eff ort to enhance 
market transparency through improved reporting schemes would benefi t 
from a coordinated eff ort at the international level.
Were such a market register to be developed, a number of design 
questions would have to be addressed, including whether the register is 
product- or application- based, and whether the register would be available 
only to regulators or to the public at large. Such an initiative could build 
on existing initiatives sponsored by non- governmental organizations, such 
as PEN, to establish market surveys of existing or emerging nanotechno-
logical applications. Whatever design were to be chosen, we believe that 
this is an area in which international cooperation could provide a fruitful 
approach towards laying the foundations for more congruent regulatory 
responses to the challenges of nanomaterials.
Risk Management and Consumer Labelling
Eff orts to promote international coordination and cooperation are cur-
rently focused on establishing the scientifi c building blocks needed for risk 
assessment. In comparison, moves towards greater coordination of risk 
management are likely to be less productive, may be premature and would 
face greater obstacles. At the same time, the internationalization of the 
nanosciences and nanotechnologies will inevitably bring any diff erences in 
risk management approaches into sharper focus, in US–EU relations and 
internationally. As more and more nanomaterials are adopted commer-
cially and enter global supply chains, diff erences in national or regional 
risk management approaches may end up complicating the free fl ow of 
goods across national boundaries. For this reason, coordination in the 
area of risk management will need to be given greater prominence on the 
international agenda in the coming years.
One important but controversial element of risk management is con-
sumer labelling. Whereas the US has expressed scepticism towards legally 
binding requirements that specifi cally target nanomaterials (see FDA, 
2007), the EU recently introduced such a requirement for cosmetics and 
the European Parliament has called for an extension of consumer labelling 
to other areas, most notably the food sector (see Falkner et al., 2009).
Stakeholders in nanomaterials oversight tend to be sharply divided on 
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the need to go beyond this state of aff airs by creating more comprehensive 
labelling requirements, and on whether more convergent approaches could 
and should be developed in this area. Some warn that labelling would be 
a costly way to inform the public about the presence of materials that will 
most likely be of little consequence to human health or the environment. 
Industry representatives, in particular, have questioned the usefulness and 
legitimacy of a general labelling requirement for all products that contain 
nanomaterials and have warned that labels might confuse consumers more 
than inform them.
On the other hand, civil society groups and others suggest that the label-
ling of nanomaterials in food and cosmetics products will be of particular 
importance, not least as a means of building consumer trust through 
enhanced transparency. Some see this becoming increasingly important as 
more and more nanomaterials enter the market. While most producer com-
panies remain sceptical about a general labelling requirement, some retail 
fi rms (for example supermarkets) are likely to view nano- labelling more 
favourably as a way of assuring consumers that no risks, whether actual 
or potential, are hidden from them. Labelling thus should be seen as part 
of a broader attempt to ensure consumers’ ‘right to know’ and ‘informed 
choice’.
The ‘informed choice’ argument for nanomaterials labelling is seen by 
proponents as a means of ensuring that consumers are free to express views 
not only on the safety of nanomaterials but also on ethical dimensions of 
the use of nanotechnologies, particularly in food and cosmetics. In this 
perspective, labelling becomes a tool for embedding nanomaterials regula-
tion in a wider social and ethical context without sacrifi cing the scientifi c 
foundations of the core risk assessment process. Opponents, however, 
have pointed out that any comprehensive labelling of nanomaterials 
would be misleading, particularly if it failed to notify consumers of specifi c 
health or environmental risks or of specifi c benefi ts of the nanomaterials. 
The question that is at the heart of such disagreements is whether ethical 
concerns that are unrelated to specifi c concerns about environmental and 
health risks are legitimate reasons for introducing a labelling regime. This 
is clearly a policy issue under continuing political contest.
In view of the contentious nature of labelling, in terms of its general 
necessity and specifi c form of implementation, it is unlikely that gov-
ernments will prioritize international eff orts to create new, mandatory, 
labelling requirements or harmonize existing ones at this time. But they 
should still consider the implications of diff erent labelling requirements, 
whether already established or newly created, for the proper functioning 
of  international trade.
Furthermore, if governments were to explore the possibility of 
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developing common approaches or standards for nanomaterials labelling, 
such an undertaking should involve a multi- stakeholder forum to engage 
relevant groups from industry and civil society in order to give full weight 
to the diff erent commercial and ethical concerns. Current transatlantic 
dialogues, such as those within the TransAtlantic Consumers Dialogue 
(TACD) and the TransAtlantic Business Dialogue (TABD), could provide 
useful forums for taking this debate forward. Such an eff ort would be less 
urgent than the creation of common building blocks for risk assessment, 
but is nevertheless important in its own right.
Strengthening Global Governance Capacity
Current eff orts to promote greater regulatory convergence have been 
focused on informal processes of communication and policy learning 
between national regulatory agencies, as well as formal and informal proc-
esses of international coordination through international bodies. In the 
transatlantic context, US and EU authorities dealing with chemicals, food 
and cosmetics regulation have engaged in regular but informal transatlan-
tic links, in order to promote the exchange of information and experiences 
with the implementation of existing nanomaterials regulations. Moreover, 
regulators, scientists, industry representatives and other stakeholders from 
civil society have established formal coordination processes through the 
OECD’s two working parties on manufactured nanomaterials and nano-
technology policy. Finally, parallel processes of international standardiza-
tion, such as those conducted under the auspices of the ISO, are aimed at 
creating technical and scientifi c standards that are central to eff ective risk 
assessment processes.
No eff orts have been undertaken as yet to create a formal, treaty-
 based, international framework for nanomaterials regulation, despite 
theoretical interest in this possibility (see, for example, Abbott et al., 
2010). Our research suggests little, if any, interest in pursuing the more 
ambitious objective of creating an international treaty on nanomaterials 
regulation. The political energies that would need to be invested in such 
a project are better spent on strengthening existing forums for interna-
tional coordination and adjusting domestic regulatory frameworks where 
needed. Given the globalized nature of nanotechnology developments 
and commercialization, however, one cannot rule out the possibility that 
an international framework treaty might be needed in the future, particu-
larly as new players from the developing world are emerging in the global 
 nanotechnology business.
In view of the ongoing and accelerating globalization of nanotech-
nologies, governments should perceive the global governance challenges 
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arising from nanomaterials in broader terms. The OECD serves an impor-
tant function as a forum for coordination among leading industrialized 
countries, but its work should be complemented by the development 
of international governance capacity in other areas, not least to ensure 
that developing countries are more involved in international decision-
 making. Other international organizations, such as the United Nations 
Environment Programme (UNEP) and the World Health Organization 
(WHO), play important roles in their respective areas of global envi-
ronmental protection and health promotion, but are only just beginning 
to identify the potential EHS risks of nanomaterials as emerging areas 
of concern. The current imbalance in the development of international 
governance capacity should thus be redressed, and developing countries 
should be better represented in global regulatory cooperation.
23.4 CONCLUSION
In order to secure the promise of nanotechnologies, governments need 
to develop adequate and appropriate regulatory oversight for nanoma-
terials. A fi rst, and critical, step in this process is the creation of sound 
and internationally agreed scientifi c building blocks for risk assessment. 
Furthermore, given persisting uncertainties regarding potential envi-
ronmental and health risks and the commercialization of nanomateri-
als, governments need to close existing knowledge gaps in these areas, 
by promoting risk- related research and establishing a comprehensive 
market register. Governments should also begin to work towards greater 
international cooperation in risk management, even if achieving coor-
dination and convergence in this area is likely to prove more diffi  cult 
to achieve. They should consider, in particular, the implications of 
potentially diverging labelling requirements for international trade and 
explore the possibility of developing common approaches or standards 
for labelling.
The EU and US are global leaders in nanosciences and nanotechnolo-
gies. They have also taken a lead in developing regulatory approaches for 
dealing with potential nanomaterials risks. Their decisions on coordina-
tion in risk assessment and risk management, within the OECD, ISO and 
other international coordination forums, will thus send important signals 
worldwide. But the EU and US should extend their leadership to other 
areas and institutions of international governance. This would ensure that 
the twin goals of securing the future of nanotechnologies while safeguard-
ing against potential environmental and health risks of nanomaterials are 
fi rmly established at the international level. It would also pave the way for 
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a better and more comprehensive representation of emerging economies 
and developing countries in international decision- making.
NOTES
1. On US research funding through the National Nanotechnology Initiative, see President’s 
Council of Advisors on Science and Technology (2008). On EU research funding through 
the Seventh Framework Programme (FP7), see http://cordis.europa.eu/fp7/cooperation/
nanotechnology_en.html
2. Available at http://www.nanotechproject.org/inventories/consumer/.
3. EU and US regulatory authorities have concluded that the existing regulatory frame-
work, consisting of a range of laws and regulations, is broadly suffi  cient to deal with 
potential risks associated with nanomaterials, and that only small adjustments or amend-
ments to regulations and implementation guidelines may be needed in order to close any 
potential gaps. See FDA (2007) and European Commission (2008).
4. See, for example, the American Bar Association’s Section Nanotechnology Project, 
which has produced a series of studies of diff erent regulatory contexts (available at http://
www.abanet.org/environ/nanotech/).
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